Ipratropium Bromide Inhalation

FDA Drug Profile — Ipratropium Bromide Inhalation

Drug Details

Generic Name
Ipratropium Bromide Inhalation
Brand Names
Ipratropium Bromide Inhalation
Application Number
ANDA217953
Sponsor
Armstrong Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
AEROSOL
Routes
RESPIRATORY (INHALATION)
Active Ingredients
IPRATROPIUM BROMIDE

Indications and Usage

1 INDICATIONS AND USAGE Ipratropium bromide HFA inhalation aerosol is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Ipratropium bromide HFA inhalation aerosol is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema